Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 2,2',5,5'-tetrachlorobiphenyl | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:36804509 | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Arhgap39 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:31388691 | 2,6-dinitrotoluene | affects expression | ISO | Arhgap39 (Rattus norvegicus) | 6480464 | 2 and 6-dinitrotoluene affects the expression of ARHGAP39 mRNA | CTD | PMID:21346803 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ARHGAP39 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ARHGAP39 mRNA | CTD | PMID:28628672 | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of ARHGAP39 intron | CTD | PMID:30157460 | Aflatoxin B2 alpha | decreases methylation | EXP | | 6480464 | aflatoxin B2 results in decreased methylation of ARHGAP39 intron | CTD | PMID:30157460 | alpha-Zearalanol | multiple interactions | ISO | Arhgap39 (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ARHGAP39 mRNA | CTD | PMID:35163327 | ammonium chloride | affects expression | ISO | Arhgap39 (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of ARHGAP39 mRNA | CTD | PMID:16483693 | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of ARHGAP39 mRNA | CTD | PMID:33212167 | benzo[a]pyrene | increases mutagenesis | EXP | | 6480464 | Benzo(a)pyrene results in increased mutagenesis of ARHGAP39 gene | CTD | PMID:25435355 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of ARHGAP39 intron | CTD | PMID:30157460 | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of ARHGAP39 promoter | CTD | PMID:27901495 | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:26238291 | benzo[e]pyrene | affects methylation | EXP | | 6480464 | benzo(e)pyrene affects the methylation of ARHGAP39 intron | CTD | PMID:30157460 | bisphenol A | decreases expression | ISO | Arhgap39 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of ARHGAP39 mRNA | CTD | PMID:25181051 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of ARHGAP39 gene | CTD | PMID:31601247 | bisphenol A | increases expression | ISO | Arhgap39 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of ARHGAP39 mRNA | CTD | PMID:34947998 | caffeine | affects phosphorylation | EXP | | 6480464 | Caffeine affects the phosphorylation of ARHGAP39 protein | CTD | PMID:35688186 | carbon nanotube | decreases expression | ISO | Arhgap39 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of ARHGAP39 mRNA | CTD | PMID:27392435 | coumestrol | decreases expression | EXP | | 6480464 | Coumestrol results in decreased expression of ARHGAP39 mRNA | CTD | PMID:19167446 | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ARHGAP39 mRNA | CTD | PMID:28628672 | dicrotophos | increases expression | EXP | | 6480464 | dicrotophos results in increased expression of ARHGAP39 mRNA | CTD | PMID:28302478 | FR900359 | affects phosphorylation | EXP | | 6480464 | FR900359 affects the phosphorylation of ARHGAP39 protein | CTD | PMID:37730182 | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ARHGAP39 mRNA | CTD | PMID:28628672 | methapyrilene | affects methylation | EXP | | 6480464 | Methapyrilene affects the methylation of ARHGAP39 intron | CTD | PMID:30157460 | oxaliplatin | multiple interactions | ISO | Arhgap39 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of ARHGAP39 mRNA | CTD | PMID:25729387 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of ARHGAP39 mRNA | CTD | PMID:29067470 | perfluorohexanesulfonic acid | decreases expression | ISO | Arhgap39 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in decreased expression of ARHGAP39 mRNA | CTD | PMID:37995155 | perfluorooctanoic acid | multiple interactions | ISO | Arhgap39 (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ARHGAP39 mRNA | CTD | PMID:35163327 | phenytoin | increases expression | ISO | Arhgap39 (Rattus norvegicus) | 6480464 | Phenytoin results in increased expression of ARHGAP39 mRNA | CTD | PMID:20345932 | silicon dioxide | decreases expression | ISO | Arhgap39 (Mus musculus) | 6480464 | Silicon Dioxide results in decreased expression of ARHGAP39 mRNA | CTD | PMID:19073995 | Soman | decreases expression | ISO | Arhgap39 (Rattus norvegicus) | 6480464 | Soman results in decreased expression of ARHGAP39 mRNA | CTD | PMID:19281266 | temozolomide | increases expression | EXP | | 6480464 | Temozolomide results in increased expression of ARHGAP39 mRNA | CTD | PMID:31758290 | topotecan | multiple interactions | ISO | Arhgap39 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of ARHGAP39 mRNA | CTD | PMID:25729387 | triptonide | decreases expression | ISO | Arhgap39 (Mus musculus) | 6480464 | triptonide results in decreased expression of ARHGAP39 mRNA | CTD | PMID:33045310 | urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of ARHGAP39 mRNA | CTD | PMID:28818685 | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of ARHGAP39 gene | CTD | PMID:29154799 | |